Foto del docente

Federico Pea

Professore ordinario

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients, «ANTIBIOTICS», 2022, 11, Article number: 33, pp. 1 - 39 [articolo]Open Access

Gatti M.; Virgili G.; Cojutti P.G.; Gaibani P.; Conti M.; Sturiale C.; Pea F.; Viale P., Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases, «MICROORGANISMS», 2022, 10, Article number: 154, pp. 1 - 8 [articolo]

Cojutti, Pier Giorgio; Rinaldi, Matteo; Zamparini, Eleonora; Rossi, Nicolò; Tedeschi, Sara; Conti, Matteo; Pea, Federico; Viale, Pierluigi, Reply to Baklouti et al., "Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?", «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2022, 66, Article number: e01908-21, pp. 1 - 1 [articolo]

Cojutti P.G.; Fornaro G.; Gatti M.; Rinaldi M.; Gaibani P.; Giannella M.; Pea F.; Viale P., Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring, «INFECTIOUS DISEASE REPORTS», 2022, 14, pp. 88 - 92 [articolo]Open Access

Gatti, Milo; Bartoletti, Michele; Cojutti, Pier Giorgio; Gaibani, Paolo; Conti, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 27, pp. 294 - 298 [articolo]Open Access

Gatti M.; Cojutti P.G.; Campoli C.; Caramelli F.; Corvaglia L.T.; Lanari M.; Pession A.; Ramirez S.; Viale P.; Pea F., A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 755075, pp. 1 - 13 [articolo]Open Access

Bassetti M.; Giacobbe D.R.; Bruzzi P.; Barisione E.; Centanni S.; Castaldo N.; Corcione S.; De Rosa F.G.; Di Marco F.; Gori A.; Gramegna A.; Granata G.; Gratarola A.; Maraolo A.E.; Mikulska M.; Lombardi A.; Pea F.; Petrosillo N.; Radovanovic D.; Santus P.; Signori A.; Sozio E.; Tagliabue E.; Tascini C.; Vancheri C.; Vena A.; Viale P.; Blasi F., A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP), «INFECTIOUS DISEASES AND THERAPY», 2021, 1, pp. 1 - 1 [replica/breve intervento]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients, «INFECTION AND DRUG RESISTANCE», 2021, 14, pp. 2461 - 2498 [articolo]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, na, pp. 1 - 22 [articolo]

Gatti M.; Pea F., Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 1271 - 1289 [articolo]

Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311, pp. 1 - 12 [articolo]Open Access

Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6”, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 833 - 834 [articolo]

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]

Falcone M.; De Angelis B.; Pea F.; Scalise A.; Stefani S.; Tasinato R.; Zanetti O.; Dalla Paola L., Challenges in the management of chronic wound infections, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2021, 26, pp. 140 - 147 [articolo]Open Access